Scolaris Content Display Scolaris Content Display

Study flow diagram (PRISMA) for all search results.

Figuras y tablas -
Figure 1

Study flow diagram (PRISMA) for all search results.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Figure 4: Forest plot of time to ulcer healing

Figuras y tablas -
Figure 4

Figure 4: Forest plot of time to ulcer healing

Figure 5: Forest plot of proportion of ulcers healed at 90 days

Figuras y tablas -
Figure 5

Figure 5: Forest plot of proportion of ulcers healed at 90 days

Figure 6: Forest plot of proportion of ulcers healed at one year (NB participants in the compression alone group in Gohel 2018 were offered ablation from 6 months)

Figuras y tablas -
Figure 6

Figure 6: Forest plot of proportion of ulcers healed at one year (NB participants in the compression alone group in Gohel 2018 were offered ablation from 6 months)

Figure 7: forest plot of ulcer recurrence (NB participants in the compression alone group of Gohel 2018 were offered ablation following ulcer healing)

Figuras y tablas -
Figure 7

Figure 7: forest plot of ulcer recurrence (NB participants in the compression alone group of Gohel 2018 were offered ablation following ulcer healing)

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 1: Ulcer healing

Figuras y tablas -
Analysis 1.1

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 1: Ulcer healing

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 2: Proportion of ulcers healed at 90 days

Figuras y tablas -
Analysis 1.2

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 2: Proportion of ulcers healed at 90 days

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 3: Proportion of ulcers healed at one year

Figuras y tablas -
Analysis 1.3

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 3: Proportion of ulcers healed at one year

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 4: Ulcer recurrence

Figuras y tablas -
Analysis 1.4

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 4: Ulcer recurrence

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 5: Thromboembolism (complications)

Figuras y tablas -
Analysis 1.5

Comparison 1: Endovenous ablation and compression vs compression alone for venous leg ulcers, Outcome 5: Thromboembolism (complications)

Summary of findings 1. Summary of findings: endovenous ablation and compression vs compression alone for venous leg ulcers

Endovenous ablation of superficial venous incompetence and compression compared with compression alone for venous leg ulcers

Patient or population: adults with venous leg ulcers.

Settings: outpatient hospital care and/or in community care

Intervention: endovenous ablation of superficial venous incompetence with standard wound care that includes compression

Comparison: standard wound care that includes compression

Outcomes

Illustrative comparative risk* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Risk with standard wound care

Risk with endovenous ablation and

standard wound care

Ulcer healing time

(measured as days from randomisation and followed‐up to 1 year)

78 days

56 days

(47.95 to 64.05)

HR 1.41 (1.36 to 1.47)

466

(2 RCTs)

⊕⊕⊕⊕
High

Risk of performance bias in both included studies was high as the nature of the interventions in the treatment groups meant that neither participants nor treating clinicians were blinded at the time treatments were performed. Blinding was not possible in these studies. The outcome was measured by blinded assessors. The outcomes in the control arms were equal to or better than those reported in the independent literature. This increases our confidence that the true effect lies close to that of the estimate of the effect, so we did not downgrade the certainty of evidence.

Proportion of ulcers healed at 90 days

(90 days follow‐up)

616 per 1000

705 per 1000

RR 1.14 (1.00 to 1.30)

466

(2 RCTs)

⊕⊕⊕⊝
Moderatea

Proportion of ulcers healed at one year (52 week follow up)

270 per 1000

215 per 1000

RR 1.08 (1.02 to 1.14 )

505 (2 RCTs)

⊕⊕⊕⊝
Moderatea

Ulcer recurrence

(1 year follow‐up)

37 per 1000

448 per 1000

RR 0.29

(0.03 to 2.48)

460

(2 RCTs)

⊕⊕⊕⊝
Lowb

Ulcer‐free time

(measured as days from healing of index ulcer to recurrence)

278

(175 to 324)

306

(240 to 328)

450

(1 RCT)

⊕⊕⊕⊝
Lowc

Ulcer‐free time was only reported by the EVRA study; it was not possible to calculate an effect estimate. We downgraded the certainty of evidence by two levels due to serious indirectness as the intervention was given to both groups.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; HR: hazard ratio; RR: risk ratio

GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.

aDowngraded one level: for serious imprecision due to wide confidence intervals.
bDowngraded two levels: one for serious imprecision due to low sample size and one for risk of bias.
cDowngraded two levels: two for very serious indirectness due to intervention being given to both groups in the EVRA trial.

Figuras y tablas -
Summary of findings 1. Summary of findings: endovenous ablation and compression vs compression alone for venous leg ulcers
Comparison 1. Endovenous ablation and compression vs compression alone for venous leg ulcers

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1.1 Ulcer healing Show forest plot

2

Hazard Ratio (IV, Fixed, 95% CI)

1.41 [1.36, 1.47]

1.2 Proportion of ulcers healed at 90 days Show forest plot

2

466

Risk Ratio (M‐H, Fixed, 95% CI)

1.14 [1.00, 1.30]

1.3 Proportion of ulcers healed at one year Show forest plot

2

505

Risk Ratio (M‐H, Fixed, 95% CI)

1.08 [1.02, 1.14]

1.4 Ulcer recurrence Show forest plot

2

460

Risk Ratio (M‐H, Random, 95% CI)

0.29 [0.03, 2.48]

1.5 Thromboembolism (complications) Show forest plot

2

506

Risk Ratio (M‐H, Fixed, 95% CI)

2.02 [0.51, 7.97]

Figuras y tablas -
Comparison 1. Endovenous ablation and compression vs compression alone for venous leg ulcers